Frequent, Low-Dose Chemo Fights Advanced Breast Cancer (HealthDay)
9th Dec 2005, 06:41 GMT
The combination of frequent but low doses of chemotherapy, along with the angiogenesis-inhibitor drug Avastin resulted in partial cancer shrinkage in some women with advanced breast cancer, according to a new study.
Frequent, Low-Dose Chemo Fights Advanced Breast Cancer (HealthDay) related news:
- Frequent, Low-Dose Chemo Fights Advanced Breast Cancer — MedicineNet Womens Health General
- Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer — EurekAlert! - Breaking News
- SABCS: Low-dose Frequent Chemotherapy Plus Avastin Shows Activity in Breast Cancer — MedPage Today.com Latest Headlines
- Bevacizumab Plus Low-Dose Chemo Shows Promise in Advanced Breast Cancer — Medscape Pharmacist Headlines
- Low-Dose Estrogen May Fight Breast Cancer (HealthDay) —
- Positive ABRAXANE Data in Early-Stage Breast Cancer and Solid Tumors Reported at San Antonio Breast Cancer Symposium — Radiology News from StratCenter.com
- Dose-dense Chemotherapy For Early Breast Cancer Found Safe, Similar To Standard Regimen — ScienceDaily Headlines: Health & Medicine
- Low-Dose Estrogen May Fight Breast Cancer — MedicineNet Menopause General
- Breast Cancer Survivors Face Increased Cancer Risk (HealthDay) —
- Less chemo for breast cancer — The Daily Herald
Latest news from UNTITLED FEED:
- Simple steps can speed heart attack care: study (Reuters)
- Hospitals want faster heart attack care (Associated Press)
- Diabetes threatens many of world's indigenous people (Reuters)
- Fast test catches heart blockages, U.S. study shows (Reuters)
- Children showing hardening of arteries -U.S. study (Reuters)
- Children showing hardening of arteries: U.S. study (Reuters)
- Two Canada professors win right to toke up at work (Reuters)
- Results mixed on Merck's new painkiller (Associated Press)
- Group gives advice on face transplants (Associated Press)
- Diabetes drug may cut heart risks: study (Reuters)